Pfs Partners, LLC Pro Qr Therapeutics N.V. Transaction History
Pfs Partners, LLC
- $151 Billion
- Q1 2024
A detailed history of Pfs Partners, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Pfs Partners, LLC holds 1,000 shares of PRQR stock, worth $1,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$1,640
Previous $1.98 Million
15.66%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
52Shares Held
17.4MCall Options Held
52.5KPut Options Held
11.8K-
Privium Fund Management B.V.5.34MShares$8.76 Million3.62% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$5.95 Million0.02% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.88MShares$4.73 Million0.19% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$1.67 Million2.19% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$1.49 Million0.5% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $117M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...